Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
Mediators of Inflammation|July 18, 2015
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future PerspectivesCinzia Rotondo, Giuseppe Lopalco, Florenzo Iannone, et al.
Clinical and Experimental Rheumatology|February 18, 2016
Changes in anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes serum levels in patients with rheumatoid arthritis following treatment with different biological drugsFlorenzo Iannone, Marilina Tampoia, Margherita Giannini, et al.
Current Rheumatology Reports|April 28, 2016
Management of Small Vessel VasculitidesGiuseppe Lopalco, Donato Rigante, Vincenzo Venerito, et al.
The Journal of Rheumatology|October 6, 2005
Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot studyFlorenzo Iannone, Marco Matucci-Cerinic, Paola Chiara Francesca Falappone, et al.
BMC Gastroenterology|February 29, 2008
Gastrointestinal symptoms and motility disorders in patients with systemic sclerodermaAgostino Di Ciaula, Michele Covelli, Massimo Berardino, et al.
Clinical Rheumatology|April 16, 2014
Paradoxical mucocutaneous flare in a case of Behçet's disease treated with tocilizumabLuca Cantarini, Giuseppe Lopalco, Antonio Vitale, et al.
Drug Development Research|November 11, 2014
Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical responseFabio Cacciapaglia, Maria Grazia Anelli, Angela Rinaldi, et al.
Mediators of Inflammation|November 9, 2018
Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab TreatmentFabio Cacciapaglia, Maria Grazia Anelli, Angela Rinaldi, et al.
The Journal of International Medical Research|September 30, 2016
Effective tumour necrosis factor-blocking therapy reduces reactive oxygen metabolite level in rheumatoid arthritisFabio Cacciapaglia, Maria Grazia Anelli, Daniela Rizzo, et al.
The Journal of Rheumatology|August 9, 2008
Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infectionClodoveo Ferri, Gianfranco Ferraccioli, Daniela Ferrari, et al.
Pageof 12